Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 3.6 to 2.6.
Financials
Financial year 2025
PHARMACIE LOUISE from Brussel, company number BE0501663016, closed financial year 2025 with a result of € -31,655 after tax. For that financial year PHARMACIE LOUISE recorded a gross margin of € 211,245 and equity of € 152,593. Compared with financial year 2024, the result moved from € -19,055 to € -31,655. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.
€ 152,593
▼ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -31,655
▼ 66 % more loss than in 2024
Profit after tax over the fiscal year.
€ 64,380
▼ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 72,593.
People and assets in 2025
2.6
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 201,905
▲ 4% vs 2024
€ 77,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,866
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 194,032
▼ 15% vs 2024
€ 35,662 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 120,930
▲ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,719
▲ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 236,517 | € 251,234 | € 215,256 | € 211,245 | ▼ 2% |
| Profit after taxes | € 12,333 | € 16,263 | € -19,055 | € -31,655 | ▼ € 12,600 |
| Equity | € 187,039 | € 203,302 | € 184,247 | € 152,593 | ▼ 17% |
| Total debts | € 435,598 | € 426,299 | € 398,003 | € 352,817 | ▼ 11% |
| Cash | € 180,409 | € 136,601 | € 93,060 | € 64,380 | ▼ 31% |
| Retained profit | € 107,039 | € 123,302 | € 104,247 | € 72,593 | ▼ 30% |
| Bank debt | € 288,156 | € 256,695 | € 228,143 | € 194,032 | ▼ 15% |
| Balance sheet total | € 622,637 | € 629,601 | € 582,251 | € 505,410 | ▼ 13% |
| Employees (FTE) | 3.1 | 3.6 | 2.7 | 2.6 | ▼ 0.1 |
By gross margin, PHARMACIE LOUISE ranks 13th of 38 companies with main activity “Detailhandel in farmaceutische producten” in Brussel that publish figures (fiscal year 2025).
Key figures of PHARMACIE LOUISE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMACIE LOUISE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIE LOUISE?
What happened at PHARMACIE LOUISE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 31,655. Source: NBB ↗
- PHARMA BUYL-LOUISE SRL became a director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
In short
From € 12,333 profit in 2022 to € 31,655 loss in 2025.
Paid € 5,517 in corporate taxes since 2022.
Best year ever: 2023, with € 16,263 profit.
On average € 81,200 of value added per employee in 2025.
Management
The stake of PHARMA BUYL-LOUISE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE LOUISEBehind PHARMACIE LOUISE is PHARMA BUYL-LOUISE SRL. The shares are held by PHARMA BUYL-LOUISE (100%).
Directors
According to the 2025 annual accounts
Director · represented by JOELLE ANTOINE
since 2021
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Louizalaan 513
1050 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Detailhandel in farmaceutische producten), 39 active companies in Brussel, largest first.
€ 825,140 gross margin · 2025
€ 793,112 gross margin · 2025
€ 559,341 gross margin · 2025
€ 528,662 gross margin · 2025
€ 485,409 gross margin · 2025
€ 414,458 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CBLUE-AS, BE
DNS
OVH DNS
Website info
Features
Security
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VAN SINTEJAN Alain Marie André(oprichter) 100%
Details
- Company number
- 0501.663.016
- VAT number
- BE 0501.663.016
- Registered office
- Louizalaan 513, 1050 Brussel
- Names & denominations
- PHARMACIE LOUISE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 November 2012
- Peppol
- Active · Active since 4 Sept 2025
- Contact
- pharmacie-ixelles.be
- Activities · NACE
Detailhandel in farmaceutische producten